ArticleArthroscopy techniques2025
Combined Unicompartmental Knee Arthroplasty and Trochlear Porous Calcium Carbonate Scaffold Implantation: Surgical Technique.
Article in Arthroscopy techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Unicompartmental knee arthroplasty (UKA) has emerged as a relatively joint-preserving option for younger, active patients with advanced osteoarthritis (OA) isolated to the medial or lateral compartment. The indication for UKA is more controversial in patients with mixed multi-compartment disease, that is, advanced knee OA in a single compartment coexisting with more focal disease in a separate location, most frequently the trochlea. Whereas some surgeons advocate ignoring patellofemoral compartment disease and proceeding with UKA, others are more cautious and indicate total knee arthroplasty (TKA) because of concerns that untreated defects in another compartment may lead to suboptimal outcomes. Because surgeons often have different age and activity thresholds for indicating UKA versus TKA, some patients are limited to-often ineffective-conservative care because the extent of disease is deemed too great for UKA yet they are considered too young for TKA. CartiHeal Agili-C (Smith & Nephew, Andover, MA), a porous calcium carbonate scaffold made from coral, promotes cartilage regeneration and offers an off-the-shelf biologic solution for osteochondral repair. It has received Food and Drug Administration approval for the treatment of degenerative defects in early OA. Combining UKA with CartiHeal Agili-C implantation offers the potential to preserve more of the native joint in patients with mixed multi-compartment disease.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.